Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FUT5 | Q11128 | 1/20 | 0.76 |
| ▸ | TGM2 | P21980 | 1/20 | 0.70 |
| ▸ | KRAS | P01116 | 4/20 | 0.66 |
| ▸ | NT5E | P21589 | 1/20 | 0.66 |
| ▸ | P2RY14 | Q15391 | 1/20 | 0.62 |
| ▸ | P2RX3 | P56373 | 2/20 | 0.61 |
| ▸ | P2RY2 | P41231 | 3/20 | 0.60 |
| ▸ | P2RY4 | P51582 | 1/20 | 0.60 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.60 |
| ▸ | DCPS | Q96C86 | 1/20 | 0.60 |
| ▸ | P2RY1 | P47900 | 3/20 | 0.57 |
| ▸ | SRC | P12931 | 1/20 | 0.57 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.57 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.57 |
| ▸ | P2RX2 | Q9UBL9 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | HINT1 | P49773 | 1/20 | 0.57 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.57 |
| ▸ | IMPDH1 | P20839 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29397556 | 1.00 | FUT5 (0.76) | FUT5TGM2KRASNT5EP2RY14 | |
| SCHEMBL14293772 | 1.00 | FUT5 (0.76) | FUT5TGM2KRASNT5EP2RY14 | |
| SCHEMBL14293912 | 1.00 | FUT5 (0.76) | FUT5TGM2KRASNT5EP2RY14 | |
| SCHEMBL29456758 | 1.00 | FUT5 (0.76) | FUT5TGM2KRASNT5EP2RY14 | |
| SCHEMBL24496886 | 1.00 | FUT5 (0.76) | FUT5TGM2KRASNT5EP2RY14 | |
| SCHEMBL9438541 | 1.00 | FUT5 (0.76) | FUT5TGM2KRASNT5EP2RY14 | |
| SCHEMBL25319857 | 1.00 | FUT5 (0.76) | FUT5TGM2KRASNT5EP2RY14 | |
| SCHEMBL14268500 | 1.00 | FUT5 (0.76) | FUT5TGM2KRASNT5EP2RY14 | |
| SCHEMBL2229602 | 1.00 | FUT5 (0.76) | FUT5TGM2KRASNT5EP2RY14 | |
| SCHEMBL30646155 | 1.00 | FUT5 (0.76) | FUT5TGM2KRASNT5EP2RY14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1129 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122038334-A | Glycosyltransferase mutant and application thereof | 南京腾蔷生物科技有限公司 | 2026-05-15 | — | — | CN | claimed |
| US-20260108547-A1 | LEVERAGING L-FUCOSE-MEDIATED SIGNALING TO INDUCE MONOCYTE-DERIVED DENDRITIC CELL POLARIZATION | H LEE MOFFITT CANCER CT & RES (US) | 2026-04-23 | — | — | US | claimed |
| EP-4703473-A1 | NON-METHYLATED CPG OLIGODEOXYNUCLEOTIDE AND APPLICATION THEREOF | Beijing Ray Medicine Biotechnology Co., Ltd. (CN) | 2026-03-04 | — | — | EP | claimed |
| US-20250361477-A1 | PRODUCTION OF AN OLIGOSACCHARIDE MIXTURE BY A CELL | INBIOSE NV (BE) | 2025-11-27 | — | — | US | claimed |
| EP-4649140-A1 | COMPOSITIONS AND METHODS FOR IDENTIFYING AND ISOLATING HUMAN HEMATOPOIETIC STEM AND PROGENITOR CELLS | The Brigham and Women's Hospital (US) | 2025-11-19 | — | — | EP | claimed |
| US-20250345420-A1 | CANCER IMMUNOTHERAPIES TO PROMOTE HYPERACUTE REJECTION | UNIV CORNELL (US) | 2025-11-13 | — | — | US | claimed |
| EP-3461890-B1 | TOTAL FERMENTATION OF OLIGOSACCHARIDES | CHR HANSEN HMO GMBH (DE) | 2025-09-24 | — | — | EP | claimed |
| US-20250250599-A1 | POLYPHOSPHATE KINASES (PPKs) FOR EFFICIENT REGENERATION OF GUANOSINE TRIPHOSPHATE (GTP) AND USE THEREOF | BEIJING UNIVERSITY OF CHEMICAL TECHNOLOGY (CN) | 2025-08-07 | — | — | US | claimed |
| EP-3813865-B1 | IMMUNODOMINANT PROTEINS AND FRAGMENTS IN MULTIPLE SCLEROSIS | UNIV ZUERICH (CH) | 2025-08-06 | — | — | EP | claimed |
| EP-4298237-B1 | SINGLE CELL GLYCAN PROFILING | 10X GENOMICS INC (US) | 2025-06-25 | — | — | EP | claimed |
| CN-114574506-A | Protein O-fucosyltransferase OsPOFUT1 encoding gene and enzyme, preparation and application thereof | 中国科学院大连化学物理研究所 | 2022-06-03 | — | — | CN | claimed |
| US-20220145342-A1 | FERMENTATIVE PRODUCTION OF CARBOHYDRATES BY MICROBIAL CELLS UTILIZING A MIXED FEEDSTOCK | CHR. HANSEN A/S (DK) | 2022-05-12 | — | — | US | claimed |
| WO-2022082224-A1 | PRODUCTION OF MEGAKARYOCYTES AND PLATELETS IN A CO-CULTURE SYSTEM | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2022-04-21 | — | — | WO | claimed |
| EP-3983557-A1 | PRODUCTION OF FUCOSYLATED OLIGOSACCHARIDES IN BACILLUS | Chr. Hansen HMO GmbH (DE) | 2022-04-20 | — | — | EP | claimed |
| CN-114369584-A | Recombinant human fucosyltransferase variant and application thereof | 北京睿脉医药科技有限公司 | 2022-04-19 | — | — | CN | claimed |
| CN-114369585-A | Fucosyltransferase mutant of recombinant helicobacter pylori and application thereof | 北京睿脉医药科技有限公司 | 2022-04-19 | — | — | CN | claimed |
| EP-3977121-A1 | A CHEMOENZYMATIC METHOD FOR THE DETECTION OF CELL-CELL PROXIMITY INTERACTION AND ISOLATION OF TUMOR-SPECIFIC ANTIGEN REACTIVE T CELLS FOR IMMUNE THERAPY | The Scripps Research Institute (US) | 2022-04-06 | — | — | EP | claimed |
| WO-2022040411-A2 | BIOSYNTHETIC PRODUCTION OF 2-FUCOSYLLACTOSE | CONAGEN INC. (US) | 2022-02-24 | — | — | WO | claimed |
| WO-2022034075-A1 | PRODUCTION OF GLCNAC CONTAINING BIOPRODUCTS IN A CELL | INBIOSE N.V. (BE) | 2022-02-17 | — | — | WO | claimed |
| WO-2022034069-A1 | PRODUCTION OF A MIXTURE OF NEUTRAL FUCOSYLATED OLIGOSACCHARIDES BY A CELL | INBIOSE N.V. (BE) | 2022-02-17 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260108547-A1 | LEVERAGING L-FUCOSE-MEDIATED SIGNALING TO INDUCE MONOCYTE-DERIVED DENDRITIC CELL POLARIZATION | MYD88, CD14, FUCA1 | FUT5 28/4885TGM2 3963/4885KRAS 3928/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.